Baidu Inc. ADS (BIDU) Financials Nov 20, 2014, 7:33
Baidu Inc. ADS (BIDU) Financials Nov 20, 2014, 7:33 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Baidu Inc. ADS
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 651.2M 1.17B 2.25B 3.54B 5.2B
Cost of Goods Sold (COGS) incl. D&A 236.63M 318.01M 604.41M 1.02B 1.91B
COGS excluding D&A 190.22M 252.71M 467.16M 782.85M 1.47B
Depreciation & Amortization Expense 46.41M 65.3M 137.25M 240.47M 431.82M
Depreciation 44.84M 63.79M 127.06M 203.34M 277.16M
Amortization of Intangibles 1.57M 1.52M 10.19M 37.13M 154.66M
Gross Income 414.57M 853.11M 1.64B 2.52B 3.3B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 179.59M 267.37M 469.53M 762.69M 1.47B
Research & Development 61.88M 106.24M 206.97M 365.75M 668.72M
Other SG&A 117.71M 161.13M 262.55M 396.94M 804.55M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 3.94M
EBIT after Unusual Expense 0 0 0 0 (3.94M)
Non Operating Income/Expense 6.7M (725,152) 235,442 71.37M 26.35M
Non-Operating Interest Income 4.78M 9.93M 52.06M 137.5M 213.07M
Equity in Affiliates (Pretax) - (1.33M) (27.83M) (46.69M) -
Interest Expense - 0 - 17.12M 72.8M
Gross Interest Expense - 0 - 17.12M 72.8M
Interest Capitalized 0 0 0 0 0
Pretax Income 246.46M 600.89M 1.21B 1.9B 1.99B
Income Tax 28.99M 79.31M 184.39M 249.8M 297.8M
Income Tax - Current Domestic 38.11M 98.45M 204.73M 259.17M 243.97M
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (9.12M) (19.15M) (20.34M) (9.37M) 53.84M
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates (33,528) - - - (945,391)
Other After Tax Income (Expense) 0 0 0 - 0
Consolidated Net Income 217.43M 521.58M 1.03B 1.65B 1.69B
Minority Interest Expense 0 0 (2.84M) (10.28M) (26.52M)
Net Income 217.43M 521.58M 1.03B 1.66B 1.71B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 - 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries 217.43M 521.58M 1.03B 1.66B 1.71B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 217.43M 521.58M 1.03B 1.66B 1.71B
EPS (Basic) 0.63 1.50 2.95 4.74 4.88
Basic Shares Outstanding 345.71M 348.05M 348.9M 349.4M 349.86M
EPS (Diluted) 0.63 1.49 2.95 4.73 4.87
Diluted Shares Outstanding 347.76M 349.18M 349.63M 349.79M 350.36M
EBITDA 281.39M 651.04M 1.31B 1.99B 2.25B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Top 5 Most Recently Viewed Articles
Welcome to New Beginnings in North Dakota As the season of relocation kicks off, North Dakota is inviting jobseekers with its innovative campaign, Find the Good Life in North Dakota. This initiative coincides with National Moving Day, marking the start of a bustling season when many families seek new horizons across the country. Embrace New Opportunities "People are on...
Continue Reading
Celebrating Industry Recognition Caseware™, a pioneer in AI-enabled audit, financial reporting, and data analytics, has recently basked in a wave of industry accolades. These recognitions underscore the company's unmatched leadership in driving innovation and delivering impactful solutions to accounting professionals worldwide. A Double Triumph for Caseware In a...
Continue Reading
Telomir Pharmaceuticals Sees Significant Pre-market Surge Shares of Telomir Pharmaceuticals Inc (NASDAQ: TELO) experienced a remarkable increase of 31%, reaching $1.86 in pre-market trading. This boost comes in the wake of encouraging preclinical results regarding their primary compound, Telomir-1. Promising Preclinical Study Results The biotechnology firm disclosed these...
Continue Reading
Market Overview for Potential Rebounds The stock market is often unpredictable, with certain stocks experiencing declines even after positive earnings reports. In recent times, some stocks have evidently fallen out of favor with investors, particularly following disappointing earnings or cautious guidance from companies. Interestingly, stocks with low expectations can...
Continue Reading
Acer Inc. Demonstrates Strong Quarter Over Quarter Growth Acer Inc. (TWSE: 2353) has recently shared impressive financial results for the third quarter of 2024, showcasing resilience and growth in a competitive market. The company reported consolidated revenues of NT$72.69 billion, reflecting an 8.3% increase compared to the previous quarter and a 7.8% rise year-on-year....
Continue Reading